The impact of surgical resection of the primary tumor on the development of synchronous colorectal liver metastasis: a systematic review

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
   PubMed Web of Science ®Google Scholar
• Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. preventive services task force. Ann Intern Med. 2008;149:659–669.
   PubMed Web of Science ®Google Scholar
• Gupta S, Sussman DA, Doubeni CA, et al. Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst. 2014;106:dju032.
   PubMedGoogle Scholar
• Van Cutsem E, Cervantes A, Nordlinger B, Group EGW, et al. Metastatic colorectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(3):iii1–iii9.
   Web of Science ®Google Scholar
• Stangl R, Altendorf-Hofmann A, Charnley RM, et al. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994;343:1405–1410.
   PubMed Web of Science ®Google Scholar
• Chua TC, Saxena A, Chu F, et al. Predictors of cure after hepatic resection of colorectal liver metastases: an analysis of actual 5- and 10-year survivors. J Surg Oncol. 2011;103:796–800.
   PubMed Web of Science ®Google Scholar
• Zitt M. Bowel first? Simultaneous resection? Liver first? Treatment options in patients with colorectal cancer and resectable synchronous liver metastases. Memo. 2011;4:79–81.
   Google Scholar
• Hillingso JG, Wille-Jorgensen P. Staged or simultaneous resection of synchronous liver metastases from colorectal cancer–a systematic review. Colorectal Dis. 2009;11:3–10.
   PubMed Web of Science ®Google Scholar
• de Haas RJ, Adam R, Wicherts DA, et al. Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg. 2010;97:1279–1289.
   PubMed Web of Science ®Google Scholar
• Mentha G, Majno PE, Allal AS, et al. Response from authors: neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg. 2007;94:386.
   PubMed Web of Science ®Google Scholar
• Jegatheeswaran S, Mason JM, Hancock HC, et al. The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review. JAMA Surg. 2013;148:385–391.
   PubMed Web of Science ®Google Scholar
• Lykoudis PM, O'Reilly D, Nastos K, et al. Systematic review of surgical management of synchronous colorectal liver metastases. Br J Surg. 2014;101:605–612.
   PubMed Web of Science ®Google Scholar
• Kelly ME, Spolverato G, Le GN, et al. Synchronous colorectal liver metastasis: a network meta-analysis review comparing classical, combined, and liver-first surgical strategies. J Surg Oncol. 2015;111:341–351.
   PubMed Web of Science ®Google Scholar
• Baltatzis M, Chan AK, Jegatheeswaran S, et al. Colorectal cancer with synchronous hepatic metastases: systematic review of reports comparing synchronous surgery with sequential bowel-first or liver-first approaches. Eur J Surg Oncol. 2016;42:159–165.
   PubMed Web of Science ®Google Scholar
• Demicheli R, Retsky MW, Hrushesky WJ, et al. The effects of surgery on tumor growth: a century of investigations. Ann Oncol. 2008;19:1821–1828.
   PubMed Web of Science ®Google Scholar
• Ceelen W, Pattyn P, Mareel M. Surgery, wound healing, and metastasis: recent insights and clinical implications. Crit Rev Oncol Hematol. 2014;89:16–26.
   PubMed Web of Science ®Google Scholar
• Glasner A, Avraham R, Rosenne E, et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol. 2010;184:2449–2457.
   PubMed Web of Science ®Google Scholar
• Maniwa Y, Okada M, Ishii N, et al. Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer. Chest. 1998;114:1668–1675.
   PubMed Web of Science ®Google Scholar
• Li TS, Kaneda Y, Ueda K, et al. The influence of tumour resection on angiostatin levels and tumour growth-an experimental study in tumour-bearing mice. Eur J Cancer. 2001;37:2283–2288.
   PubMed Web of Science ®Google Scholar
• Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun. 2003;17(l1):S27–S36.
   Web of Science ®Google Scholar
• Tamburini A, Castiglioni A, Orsenigo E, et al. Colon cancer surgery increases levels of vascular endothelial growth factor open more than laparoscopic approach. Results of a randomised controlled trial. Eur J Surg Oncol. 2012;38:829.
   Google Scholar
• Kumara S, Miyagaki H, Yan X, et al. Minimally invasive colorectal resection is associated with persistently elevated levels of interleukin-8(IL8) during the first month after surgery that may promote residual cancer growth and metastasis. Surg Endosc Other Int Tech. 2013;27:S321.
   Google Scholar
• Clancy C, Burke JP, Barry M, et al. A meta-analysis to determine the effect of primary tumor resection for stage IV colorectal cancer with unresectable metastases on patient survival. Ann Surg Oncol. 2014;21:3900–3908.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
   PubMed Web of Science ®Google Scholar
• Adam R, de Gramont A, Figueras J, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41:729–741.
   PubMed Web of Science ®Google Scholar
• Peeters CF, Westphal JR, de Waal RM, et al. Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients. Int J Cancer. 2004;112:554–559.
   PubMed Web of Science ®Google Scholar
• Peeters CF, de Waal RM, Wobbes T, et al. Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation. Int J Cancer. 2006;119:1249–1253.
   PubMed Web of Science ®Google Scholar
• Scheer MG, Stollman TH, Vogel WV, et al. Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor. J Nucl Med. 2008;49:887–891.
   PubMed Web of Science ®Google Scholar
• Slesser AA, Khan F, Chau I, et al. The effect of a primary tumour resection on the progression of synchronous colorectal liver metastases: an exploratory study. Eur J Surg Oncol. 2015;41:484–492.
   PubMed Web of Science ®Google Scholar
• Demicheli R, Retsky MW, Hrushesky WJ, et al. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures. Nat Clin Prac Oncol. 2007;4:699–710.
   PubMedGoogle Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423–1437.
   PubMed Web of Science ®Google Scholar
• O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315–328.
   PubMed Web of Science ®Google Scholar
• O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277–285.
   PubMed Web of Science ®Google Scholar
• Volpert OV, Lawler J, Bouck NP. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. Proc Natl Acad Sci USA. 1998;95:6343–6348.
   PubMed Web of Science ®Google Scholar
• Jimenez B, Volpert OV, Crawford SE, et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med. 2000;6:41–48.
   PubMed Web of Science ®Google Scholar
• Kantola T, Vayrynen JP, Klintrup K, et al. Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers. Br J Cancer. 2014;111:1605–1613.
   PubMed Web of Science ®Google Scholar
• Shantha Kumara HM, Tohme ST, Yan X, et al. Plasma levels of angiostatin and endostatin remain unchanged for the first 3 weeks after colorectal cancer surgery. Surg Endosc. 2011;25:1939–1944.
   PubMed Web of Science ®Google Scholar
• Shantha Kumara H, Sutton E, Bellini G, et al. Significantly elevated levels of proangiogenic proteins in wound fluids after colorectal cancer resection are a likely source of the persistently elevated plasma levels of proangiogenic proteins noted post-surgery. Dis Colon Rectum. 2016;59:e126–e1e7.
   Web of Science ®Google Scholar